IRINOTECAN WKT irinotecan hydrochloride 40mg/2mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

irinotecan wkt irinotecan hydrochloride 40mg/2ml injection vial

wockhardt bio pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: lactic acid; water for injections; hydrochloric acid; sorbitol; sodium hydroxide - irinotecan injection is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan injection is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN WKT irinotecan hydrochloride 500mg/25mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

irinotecan wkt irinotecan hydrochloride 500mg/25ml injection vial

wockhardt bio pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: sorbitol; sodium hydroxide; hydrochloric acid; lactic acid; water for injections - irinotecan injection is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan injection is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN WOCKHARDT irinotecan hydrochloride 300mg/15mL injection vial Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

irinotecan wockhardt irinotecan hydrochloride 300mg/15ml injection vial

wockhardt bio pty ltd - irinotecan hydrochloride trihydrate, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: lactic acid; water for injections; sorbitol; hydrochloric acid; sodium hydroxide - irinotecan injection is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan injection is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

viatris uk healthcare ltd - granisetron hydrochloride - oral tablet - 2mg

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

a a h pharmaceuticals ltd - granisetron hydrochloride - oral tablet - 2mg

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

phoenix healthcare distribution ltd - granisetron hydrochloride - oral tablet - 2mg

Granisetron 1mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 1mg tablets

apc pharmaceuticals & chemicals (europe) ltd - granisetron hydrochloride - oral tablet - 1mg

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

apc pharmaceuticals & chemicals (europe) ltd - granisetron hydrochloride - oral tablet - 2mg

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

alliance healthcare (distribution) ltd - granisetron hydrochloride - oral tablet - 2mg

Granisetron 2mg tablets Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

granisetron 2mg tablets

sigma pharmaceuticals plc - granisetron hydrochloride - oral tablet - 2mg